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Abstract: 
 
Regardless of medical advancements, new HIV infections persist. Young adults are most often 
newly infected, thus research is needed to assess medication adherence barriers specific to young 
adults with HIV. The data were abstracted from medical charts to include both self-reported 
behavioral and psychological distress data and HIV parameters in 2013 among patients aged 18–
30 years. Descriptive and logistic regression analyses were conducted to identify factors related 
to viral suppression and sexually transmitted infection (STI) status. A total of 335 individuals 
presented for care during a 12-month period at a single clinic. The majority were African 
American and had a mean age of 25.6 years. Nearly all had current prescriptions of antiretroviral 
therapy (ART). Among those receiving ART, almost three-quarters were virally suppressed, as 
measured by 200 copies/mL. STI tests are conducted annually and by assessed need; 30% of this 
sample had at least 1 bacterial STI diagnosis within the last year. Psychological distress 
symptoms were more common among individuals who were not virally suppressed, compared to 
those who were virally suppressed. Women and individuals with moderate to severe symptoms 
of depression had higher odds of having unsuppressed viral loads. The independent factors 
associated with having any STIs were being African American or other minorities and having 
two or more sex partners. Our findings related to how young adults are managing their HIV care 
suggest that increased efforts aimed to prevent additional STIs and manage psychological 
distress will likely reduce transmission risks. 
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Article: 
 
Introduction 
 
Despite tremendous advancements in HIV treatment, approximately 50,000 new HIV infections 
occur annually in the U.S.; these rates have not changed in over a decade (Bangsberg et al., [2]; 
CDC, [5]). It is estimated that there are 1.1 million individuals with HIV in the U.S., and yet only 
approximately 20% have been retained in care, started on antiretroviral therapies (ARTs) and 
attained an undetectable HIV viral load (Gardner, McLees, Steiner, Del, & Burman, [10]). Our 
current best prevention strategies for individuals with HIV are ART, which has shown to reduce 
HIV transmission risk by 96%. Thus, getting infected individuals identified, in care, and on 
medication is a public health priority (Cohen et al., [7]). Moreover, virologic suppression is one 
of the most important predictors of patient outcome (El-Khatib et al., [9]; Saberi, Caswell, 
Amodio-Groton, & Alpert, [28]). Therefore, it is critically important that we identify and address 
factors that result in poor virologic outcomes. 
 
Current trends indicate that older adolescents and young adults are most at risk for HIV 
infection. The HIV incidence rates of infection among 20–24 year olds were 36.4/100,000 for 
20–24 year olds and 35.2/100,000 among ages 25–29, meaning 2 of every 5 infections in the 
U.S. occur among young people (Kaiser Family Foundation, [13]). Specifically in the St. Louis 
metropolitan area, there were 94 incident cases of HIV in 13–24 year-olds and 86 incident cases 
in 25–34 year-olds in 2011 with a state-wide prevalence rate of 202.5–319.3/100,000 individuals 
with HIV (CDC, [5]). Also in the St. Louis area, between 1997 and 2002, 73% of those 
diagnosed with HIV were linked to care within 1 year (Perkins, Meyerson, Klinkenberg, & 
Laffoon, [23]). Overall, Gardner's cascade suggests that young adults are least likely to be 
diagnosed, linked to or retained in care, prescribed ART, or achieve viral suppression (Gardner 
et al., [10]). 
 
HIV testing, care linkage, and continued treatment each have different barriers, especially for 
youth (Philbin, Tanner, Duval, Ellen, Kapogiannis, et al., [24]; Philbin, Tanner, Duval, Ellen, 
Xu, et al., [25]; Tanner et al., [33]). Prevention challenges unique to youth include a low 
perception of HIV risk, low rates of testing, low rates of condom use, high rates of other STIs, 
having older sex partners, substance use, homelessness, insufficient education, and feelings of 
isolation (Anema et al., [1]; CDC, [3]; Mustanski & Newcomb, [19]; Philbin, Tanner, Duval, 
Ellen, Kapogiannis, et al., [24]; Philbin, Tanner, Duval, Ellen, Xu, et al., [25]; Tanner et al., 
[33]). 
 
Challenges to HIV medication adherence across the lifespan are associated with social 
determinants of health including employment, income, race, stable housing, experiences of 
discrimination, neighborhood conditions, and psychiatric disorders, including substance use; all 
of these factors complicate HIV management (Cohn et al., [8]; Mayer et al., [16]; Phillips et al., 
[26]). Little is known about the multi-level barriers to continued engagement in care for young 
adults. Yet, mental health issues have commonly been associated with medication nonadherence 
among young adults engaged in care (Mustanski & Newcomb, [19]; Outlaw et al., [20]; 
Wilkinson et al., [34]). Additionally, feelings of optimism about treatment options are connected 
with increased sexual risk behavior among young adult gay and bisexual males (Huebner, 
Rebchook, & Kegeles, [12]). Gaps in understanding barriers to continued engagement in care for 
youth persist. 
 
Accordingly, the purpose of this study was to examine the association between mental health, 
sexual behaviors, and viral load suppression among young adults living with HIV. 
 
Methods 
 
This was a cross-sectional study of sociodemographic characteristics, psychological distress 
symptoms, HIV transmission risk behaviors, and their association with HIV management, as 
measured by viral load suppression. Medical records were abstracted for patients aged 18–30 
years who received care at the Washington University HIV Clinic in St. Louis, Missouri, 
throughout 2013. To complement the medical records, standard of care behavioral assessments 
conducted during regular clinic visits were also abstracted. As not all patients that were seen in 
2013 with medical records had completed an assessment in that same period, we used the most 
recent completed assessment between 2012 and 2013; all patients with at least one complete 
assessment were eligible to participate. Washington University School of Medicine Human 
Research Protection Office approved this study. 
 
Measures 
 
The computer-based behavioral assessment was conducted while each patient waited for their 
provider. These assessments included measures of demographic characteristics (employment, 
education, and annual income), depressive symptomatology as measured by the Patient Health 
Questionnaire (PHQ-9), which includes an item related to suicidal ideation (Spitzer, Kroenke, 
Williams, & the Patient Health Questionnaire Primary Care Study Group, [32]) and anxiety 
symptoms as measured by the Generalized Anxiety Disorder-7 (GAD-7) (Spitzer, Kroenke, 
Williams, & Lowe, [31]). The PHQ-9 had a Cronbach's α reliability of.89 and the GAD-7 had.87 
in this sample. HIV transmission risk behaviors assessed included: condom use at last sex, 
number of partners in the last 3 months, alcohol use in last 7 days, and illicit drug use 
(crack/cocaine, speed/methamphetamine, heroin/other nonprescription opioids) within the past 
30 days. 
 
Data abstracted from medical charts included age, race, current CD4 cell count, plasma HIV 
RNA level, and receipt of ART; as well as sexually transmitted infections (STIs) that were 
diagnosed during the previous 12 months (gonorrhea, chlamydia, and/or trichomoniasis). Testing 
for gonorrhea, chlamydia, and syphilis is performed at least annually in all patients. ART was 
defined as the use of at least three drugs from two different antiretroviral drug classes, including 
Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, Non-Nucleoside Reverse 
Transcriptase Inhibitors, or Integrase Strand-Transfer Inhibitors. Virologic suppression was 
defined as having an HIV RNA level of <200 copies/mL, as the sensitivity of the standard test 
was available at the time. 
 
HIV viral load, the dependent variable, was dichotomized (<200 copies/mL and >200 
copies/mL) to define virologic suppression. Education levels were dichotomized: <high school 
graduate/GED or >than a high school degree. Employment status was dichotomized into 
unemployed (including receiving disability benefits) and employed (part- or full-time). Annual 
income was dichotomized into < and >$10,000. Depression and anxiety severity were both 
dichotomized to those who expressed symptoms of none to mild versus moderate to severe 
depression scores (>15) and anxiety scores (>10) within the past 2 weeks. Age was dichotomized 
to assess for differences between older adolescents and young adults (18–24, 25–30 years). 
Alcohol consumption was dichotomized to <4 drinks reported per week and >5 drinks per week; 
in previous research, we identified that this low threshold was associated with being virally 
unsuppressed (Shacham, Agbebi, Stamm, & Overton, [29]). 
 
Statistical analyses 
 
Descriptive analyses were conducted. Bivariate analyses (chi-square) were used to assess 
differences in the sample by sociodemographic characteristics, psychological distress symptoms, 
and HIV transmission risk behaviors with HIV viral loads (Shacham, Nurutdinova, Onen, 
Stamm, & Overton, [30]). HIV viral loads were used as a proxy for medication adherence 
(Shacham et al., [30]). Logistic regression analyses were conducted among individuals with ART 
and the final model was presented as the best fit based on likelihood ratios. 
 
We also conducted bivariate comparisons between individuals having 1 STI and more than 1 in 
the previous 12 months. Logistic regression analyses were conducted, only among individuals 
receiving ART, and the final model was presented as the best fit using likelihood ratios. 
Bivariate tests were two tailed and p < .05 was considered significant. Data analyses were 
performed using SPSS software (version 21.0).The factors included in the logistic regression 
were significant in bivariate analyses <0.10 (age, race, gender, depressive symptomatology, 
anxiety symptomatology, and suicidal ideation). 
 
Results 
 
Sample description 
 
A total of 335 young adults (18–30 year olds) presented for care at this HIV clinic during the 12-
month period in 2013. The majority were African American (n = 290, 86.6%), male (n = 251, 
74.9%), and had a mean age of 25.6 (SD = 2.8). Nearly 15% of the sample considered 
themselves homeless (n = 44), while about 40% were employed (n = 129). Almost all of the 
participants were prescribed ART (n = 305, 91%) and about two-thirds of the entire sample were 
virally suppressed (viral load < 200 copies/mL, n = 227, 67.8%). Among individuals receiving 
ART, 72.8% were virally suppressed. Nearly the entire sample (n = 301; 90.0%) had CD4 cell 
counts ≥200 cells/mm3. Table 1 provides additional details of the sample. 
 
Alcohol and illicit drug use patterns 
 
When assessing illicit drug use, 3% reported ever injecting drugs. In the last 30 days, 37.3% 
reported using marijuana (n = 125), 3.3% reported using crack or cocaine (n = 11), 2.1% reported 
using speed/methamphetamine (n = 7), and 2.4% reported using heroin/opiates (n = 8) at least 
once in the last month. A majority (n = 208, 62%) endorsed alcohol consumption in the last 3 
months and of those, only 5.1% (n = 17) reported drinking >5 drinks per week while 57.0% 
consumed <4 drinks in the previous week, among those who reported drinking alcohol within the 
last 3 months. 
 
Table 1. Sample characteristics (n = 335). 
 n % 
Race   
 African American/Other minorities 290 86.6 
 Caucasian 45 13.4 
Gender   
 Male 251 74.9 
 Female 77 23.0 
 Transgender (Male to Female) 7 2.1 
Mean age 25.6 (SD 2.8)  
 18–24 127 37.9 
 25–30 208 62.1 
Income (n = 325)   
 <$10,000 147 43.9 
 ≥$10,000 178 53.1 
Education (n = 258)   
 ≤ High school/equivalent 146 43.6 
 >High school 112 33.4 
Homeless (n = 258)   
 No 214 63.9 
 Yes 44 13.1 
Employment (n = 258)   
 Unemployed 129 38.5 
 Employed full-time or part-time 129 38.5 
Receiving ART 305 91 
HIV viral load (n = 329)   
 <199 copies/mL 227 67.8 
 ≥200 copies/mL 102 30.4 
CD4 cell count   
 <199 cells/mm3 33 9.9 
 ≥200 cells/mm3 302 90.1 
STI within last 12 months   
 One 54 16.1 
 Two or more 48 14.3 
STI by type   
 Gonorrhea/chlamydia 60 17.9 
 Syphilis 126 37.6 
 Trichomoniasis 7 2.1 
Number of partners within the last 3 months (n = 283)   
 One 70 20.9 
 Two or more 37 11.0 
Reported condom use at last sex (n = 246) 198 59.1 
Depressive symptoms (n = 245)   
 None-mild 206 61.5 
 Moderate-severe 39 11.6 
Anxiety symptoms (n = 235)   
 None-mild symptoms 183 54.6 
 Moderate-severe symptoms 52 15.5 
Suicidal ideation (n = 245) 45 13.4 
Average drinks per week   
 <4 drinks 191 57.0 
 ≥5 or more 17 5.1 
Reported marijuana use (n = 228) 125 37.3 
Reported crack/cocaine use (n = 235) 11 3.3 
Reported methamphetamine/speed use (n = 233) 7 2.1 
Reported heroin/opiate use (n = 232) 8 2.4 
Reported injected drug use (n = 236) 11 3.3 
 
Psychological distress symptoms 
 
As identified by the PHQ-9, moderate to severe depressive symptoms were endorsed among 
11.6% of participants (n = 39) and 15.5% presented moderate to severe symptoms of anxiety 
(n = 52) according to the GAD-7. Additionally, 13.4% of participants endorsed having suicidal 
ideation within the previous 2 weeks (n = 45). 
 
Table 2. Bivariate and predictive sociodemographic associations with HIV viral suppression. 
 
Viral load < 200 
copies/mL, n (%) 
Viral load ≥ 200 
copies/mL, n (%) 
p-
Value 
Adjusted odds 
ratio 95% CI 
Race   .033   
 African American/other 
minorities 191 (66.8) 95 (33.2)  3.762 
.057–
1.243 
 Caucasian 36 (83.7) 7 (16.3)  Ref  
Gender   .002   
 Male 182 (74.3) 63 (25.7)  Ref  
 Female 42 (54.5) 35 (45.5)  3.220 
1.512–
6.858 
Age   .066   
 18–24 78 (62.9) 46 (37.1)  2.009 
.997–
4.045 
 25–30 149 (72.7) 56 (27.3)  Ref  
Income   1.0   
 <$10,000 102 (69.9) 44 (30.1)    
 ≥$10,000 120 (69.4) 53 (30.6)    
Education   .889   
 ≤High school/equivalent 102 (70.8) 42 (29.2)    
 >High school 80 (72.1) 31 (27.9)    
Homeless 29 (65.9) 15 (34.1) .367   
Employment   .782   
 Unemployed 90 (70.3) 38 (29.7)    
 Full or part-time 92 (72.4) 35 (27.6)    
STI   .698   
 None 158 (69.6) 69 (30.4)    
 One or more 67 (67.0) 33 (33.0)    
Average drinks per week   .582   
 <4 drinks per week 135 (71.4) 54 (28.6)    
 ≥5 drinks per week 11 (64.7) 6 (35.3)    
Depressive symptoms   .000   
 None-mild 158 (77.8) 45 (22.2)  Ref  
 Moderate-severe 16 (41.0) 23 (59.0)  3.555 
1.255–
10.071 
Suicidal ideation 24 (53.3) 21 (46.7) .003 1.278 
.514–
3.178 
Anxiety symptoms   .004   
 None-mild 142 (78.9) 38 (21.1)  Ref  
 Moderate-severe 30 (57.7) 22 (42.3)  1.385 
.537–
3.573 
No condom use at last sex 31 (17) 1723.9 .287   
Number of partners within the 
last 3 months   .125   
 One partner 104 (71.7) 41 (28.3)    
 Two or more partners 83 (62.9) 49 (37.1)    
Note: Counts less than 5. 
Sexual health indicators 
 
Nearly 60% reported condom use at last sex, 20% had had 1 sexual partner in the last 3 months, 
and 11% had 2 or more partners in the last 3 months. One-third of (n = 102) of the sample had at 
least 1 STI diagnosis (gonorrhea, chlamydia, syphilis, trichomoniasis) within the last year and 
there were 193 total STI events. Of the 102 individuals with an STI, 47% had 2 STIs or more in 
the same time period. 
 
Associations with viral load suppression 
 
The lack of viral suppression was associated with being African American or other minority, 
female, endorsing depressive symptoms, anxiety symptoms, and expressing suicidal ideation 
within the previous 2 weeks (p < .05 for all). Individuals with moderate to severe symptoms of 
depression were 3.56 times (95% CI 1.26–10.07) more likely to be virally unsuppressed. Women 
had higher odds of having unsuppressed viral loads (3.220 OR, 95% CI 1.51–6.86). There were 
no significant differences between younger (18–24 years) and older (25–30) cohorts, with 
respect to viral suppression. Table 2 depicts these relationships. 
 
Associations with having STIs 
 
Having a diagnosis of an STI in the previous 12 months was associated with being African 
American or other minority, having two or more partners, being male, and having used crack or 
cocaine in the past 30 days (p < .05 for all). Reported methamphetamine/speed, heroin, and 
injected drug use all had cell counts of less than 5. Individuals, who had two or more partners 
within the past 3 months, were African American/other minorities, and male had higher odds of 
having more than one STI compared to those with no STI diagnosis. The independent factors 
associated with having any STIs were being African American or other minority (OR = 3.96, 
95% CI 1.04–15.13) and having two or more sex partners (OR = 2.81, 95% CI 1.33–5.92). Table 
3 shows these results. 
 
Discussion 
 
The purpose of this study was to identify challenges that interrupt consistent care among young 
adults with HIV. A large proportion of the sample presented with undetectable viral load, yet 
those having unsuppressed viral loads were more likely to be African American, female, and 
endorsing moderate to severe symptoms of anxiety and depression. Additionally, having any 
STIs within the previous 12 months was independently associated with being African American 
and having 2 or more sex partners. These findings suggest additional focus on effectively 
addressing psychological distress symptoms and STI prevention efforts among African American 
and female patients are necessary. 
 
To date, there have been several successful interventions focusing on mental health among 
young individuals with HIV (Murphy, Chen, Naar-King, & Parsons for the Adolescent Trials 
Network, [17]; Parsons, Lelutiu-Weinberger, Botsko, & Golub, [21]). Additional interventions 
and resources are needed though, as interventions that have shown to be effective have often 
relied upon having psychologists or trained mental health clinicians. With the transition to the 
Affordable Care Act, there are likely to be challenges to continued comprehensive care that has 
been supported with Ryan White Care Act, namely HIV-related mental health care and case 
management (Patient Protection and Affordable Care Act, [22]). 
 
Table 3. Bivariate and predictive sociodemographic associations with STI status. 
 
No 
STIs, n (%) 
One or more 
STI, n (%) 
p-
Value 
Adjusted odds 
ratio 95% CI 
Race   .005   
 African American/other minorities 192 (66.7) 96 (33.3)  3.964 
1.039–
15.127 
 Caucasian 39 (86.7)  6(13.3)  Ref  
Gender   .002    
 Male 164 (65.6) 86 (34.4)    
 Female 64 (84.2) 12 (15.8)     
Age   .327   
 18–24 83 (65.9) 43 (34.1)    
 25–30 148 (71.5) 59 (28.5)    
Income   .277    
 <$10,000 96 (65.8) 50 (34.2)    
 ≥$10,000 127 (71.8) 50 (28.2)    
Education   .310   
 ≤High school/equivalent 102 (70.3) 43 (29.7)    
 >High school 74 (66.7) 37 (33.3)    
Homeless 27 (61.4) 17 (38.6) .284   
Employment   .686   
 Unemployed 86 (67.2) 42 (32.8)    
 Full or part-time 90 (70.3) 38 (29.7)    
Average drinks per week   .272   
 <4 drinks per week 123 (64.7) 67 (35.3)    
 ≥5 drinks per week 13 (81.2) 3 (18.8)    
Moderate-severe depressive symptoms 24 (61.5) 15 (38.5) .192   
Suicidal ideation 27 (60.0) 18 (40.0) .112   
Moderate-severe anxiety symptoms 34 (65.4) 18 (34.6) .366   
Receiving ART 214 (70.6) 89 (29.4) .145   
HIV viral load   .698   
 <200 copies/mL 158 (70.2) 67 (29.8)    
 ≥200 copies/mL 69 (67.6) 33 (32.4)    
CD4 cell count   .115   
 <199 cells/mm3 27 (81.8) 6 (18.2)    
 ≥200 cells/mm3 204 (68.0) 96 (32.0)    
No condom use at last sex 33 (19.2) 15 (20.5) .861   
Number of partners within the last 3 
months   .041   
 One partner 107 (73.8) 38 (26.2)  Ref  
 Two or more partners 85 (62.0) 52 (38.0)  2.809 1.333–5.917 
Note: Counts less than 5. 
 
More in-depth research needs to be conducted to assess psychiatric needs among young adults 
with HIV to determine severity of the symptoms assessed and directionality of relationships 
between medication adherence and distress. Additionally, determining differences between 
diagnostic major depression disorder and generalized anxiety disorder as compared to symptoms 
of distress is imperative in order to develop and test appropriate interventions to address these 
symptoms. Furthermore, suicidality among this population needs to be explored more 
thoroughly, as the proportion of the sample endorsing suicidal ideation was more substantial than 
previously reported in adult clinic populations (Lawrence et al., [14]). Previous studies have also 
demonstrated this disturbing trend among LGBT youth (Mustanski, Andrews, Herrick, Stall, & 
Schnarrs, [18]). 
 
Specifically examining how African Americans experience this infection is imperative. Research 
continues to assess the high infection rates and call for continued focus on reducing infection 
rates among young African American men who have sex with men (YAAMSM). This study 
sample included all patients receiving HIV care who are 18–30 years old; most of which was 
YAAMSM. While engaged in care, there persists a need to develop effective interventions for 
care engagement and medication adherence to achieve undetectable viral loads to improve health 
outcomes and reduce transmission efficiency. To date, the CDC currently has only one effective 
intervention promoted for this population (CDC, [4]). It is clear from our data that interventions 
focused on improving mental health symptoms will be important to improving outcomes and 
reducing transmission rates among YAAMSM. 
 
Additionally, women continue to experience HIV infection in a different manner as well. 
Previous research identified specific support services that were female-oriented (Gurung, Taylor, 
Kemeny, & Myers, [11]), yet younger patients may need different types of interventions, as they 
have unique needs (e.g., reproductive health) in managing their HIV infection. 
 
While having a current diagnosis of an STI was not associated with viral suppression, it does 
suggest unprotected sexual behaviors resulting in exposure of both partners to HIV and/or other 
STIs. This finding suggests a limited reduction in engagement in sexual risk behaviors, 
regardless of engagement in HIV care or attaining an undetectable viral load. Thus, clarifying 
STI prevention messages among individuals with HIV, particularly those with unsuppressed viral 
loads and/or are not yet fully adherent to ART, is necessary to prevent ongoing transmission of 
HIV (Mayer et al., [15]; Powers, Poole, Pettifor, & Cohen, 2008). Future studies need to 
incorporate long-term follow-up to assess whether viral load continues to be suppressed even 
when cases of STIs exist, as research suggests increasing HIV viral loads in the presence of other 
STIs (Champredon et al., [6]). 
 
One limitation to this study is that data were collected in only one clinic site. While these 
findings were specific to young adults with HIV who are engaged in care; yet these results offer 
opportunities to guide the development of interventions and further research directions. We 
utilized a cross-sectional measure of viral loads, understanding that there may be anomalies in 
this measure that are not related to adherence. Further, self-reported medication adherence was 
not measured and thus, could not be included in the analyses. To our knowledge, there were no 
systematic medication adherence interventions occurring at the same time, beyond the standard 
of care protocol, which includes having providers encourage patients take their medication daily. 
Longitudinal assessments of predictors of viral load suppression would provide more 
comprehensive results to offer detailed intervention opportunities related to mental health, ART 
adherence, and sexual health messaging. 
 
Identifying and addressing youth-related issues in HIV care is imperative for transmission 
reduction and improving health outcomes among this population. In the era of promotion of 
"Treatment as Prevention" and Pre-Exposure Prophylaxis, it is important to understand where 
significant barriers to medication adherence exist. As current guidelines recommend early ART 
for all patients with HIV, new adherence challenges will arise. Specifically, youth have not had 
personal experience with morbidity and mortality associated with untreated HIV infection 
resulting in reduced urgency of managing their HIV care. Thus, to improve outcomes among 
young adults with HIV, we must continue to evaluate factors associated with care engagement 
and long-term adherence to ART regimens in otherwise healthy youth. 
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